Your session is about to expire
← Back to Search
DETECTion of PeriOperative Atrial Fibrillation After Noncardiac Surgery (DETECT-POAF Trial)
N/A
Recruiting
Led By David Conen, MD, MPH
Research Sponsored by Population Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 35 days of non-cardiac surgery
Awards & highlights
No Placebo-Only Group
Summary
This is a multicentre prospective cohort study where patients will receive up to 14 days of continuous ECG monitoring by wearing a portable monitoring device, starting within 72 hours after noncardiac surgery.
Eligible Conditions
- Atrial Fibrillation
- Atrial Flutter
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 35 days of non-cardiac surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 35 days of non-cardiac surgery
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Incidence of clinically important post-operative atrial fibrillation/atrial flutter
Secondary study objectives
Multivariate odds ratio of risk factors associated with the occurrence of clinically important POAF
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Study CohortExperimental Treatment1 Intervention
Participants will receive up to 14 days of continuous cardiac monitoring
Find a Location
Who is running the clinical trial?
Population Health Research InstituteLead Sponsor
164 Previous Clinical Trials
717,764 Total Patients Enrolled
33 Trials studying Atrial Fibrillation
54,374 Patients Enrolled for Atrial Fibrillation
David Conen, MD, MPHPrincipal InvestigatorPopulation Health Research Institute
2 Previous Clinical Trials
5,479 Total Patients Enrolled
2 Trials studying Atrial Fibrillation
5,479 Patients Enrolled for Atrial Fibrillation
Michael K Wang, MDPrincipal InvestigatorPopulation Health Research Institute